As a bioengineering AI graduate from Mayo Graduate School, Mayo Clinic, and a visionary CTO and AI-driven healthcare innovator, Gordon has redefined medical technology by integrating cutting-edge AI algorithms, big data, and cloud computing to revolutionize clinical decision-making, diagnostic imaging, and patient management. With deep technical expertise honed at Mayo Clinic, IBM, and multiple successful startups, I have spearheaded groundbreaking AI solutions—including early brain tumor detection algorithms, 3D imaging reconstruction, and the AI-driven Patient Referral Cloud now used by 400+ hospitals across the U.S. Gordon’s entrepreneurial acumen has led to the founding and co-founding of three startups, including newScale (acquired by Cisco) and Outcome Software, showcasing my ability to turn AI-driven concepts into high-growth, scalable ventures.
As founder and CTO at Roundtree Lab, I have led cross-national AI development teams (U.S. & India), engineered next-generation AI-EHR systems, and cut multimillion-dollar costs for hospitals by replacing high-cost legacy systems (Epic, Cerner) with AI-powered, cloud-based platforms. At IBM, Gordon engineered robust IT architectures that propelled Telecom sales to USD 220 million within one year. Gordon secured Fortune 500 clients like Starbucks, Coca-Cola, HP, and AT&T. Beyond enterprise transformation, Gordon played a pivotal role in AI-driven fintech, architecting Wells Fargo’s online banking platform and Charles Schwab’s trading ecosystem.
With a proven track record in AI innovation, enterprise strategy, and global technology leadership, Gordon is driving the next era of AI-powered healthcare, saving lives, reducing costs, and reshaping medical infrastructure on a global scale.